Your company can become a partner of a unique, truly innovative program in Europe
d·Health Barcelona depends on the generosity and support of a number of organizations and people.
Our thanks to those who have supported and continue to support the program.
If you're interested in how you can support d·HEALTH Barcelona, please contact Valentina Isetta (email@example.com).
Have a look to our team of supporters.
Jorge Juan is director of Innovation and member of the Management Board of EIT Health. He worked as Head of Academics at Moebio and director of e-Health and Health 2.0 at Hospital Sant Joan de Déu in Barcelona.
Ari Silverman, Healthcare Investor and Business Builder at MAVIE Technologies, has extensive experience in company/product growth strategies, commercial operations transformations, digital strategies, government collaboration, and talent and leadership development.
Cherif Bousselham has expertise in Business Development, Product Management, Marketing Strategy, Medical Devices & Pharma. He also workd as Product Specialist DePuy Synthes global Orthopaedics at Johnson & Johnson.
Tora Sefeldt describes herself as designer, facilitator and leader of learning processes. She is been working at KAOSPILOT for more than ten years.
Raquel Riera is Director of Moebio at Biocat (www.biocat.cat), the organization that coordinates and promotes the biotechnology, biomedicine and medical technology sector in Catalonia, from February 2006. She holds a Master in Business Administration for ESADE, as well as the 5-year combined undergraduate program. She has experience in developing projects in the healthcare sector for several types of clients, including insurance companies, pharmaceutical companies and healthcare providers, among others. After more than 5 years doing specialized consultancy in life sciences in Antares Consulting and EY, she joined Biocat to manage projects related to Innovation and promotion of entrepreneurship in medical devices.
After her clinical immersion at Institut Guttmann, she worked on her own projct Lolliclean, a device for oral hygiene in kids with special needs. She is MOEBIO Senior Project Manager at Biocat.
Josep Maria Martorell, Associate Director of the Barcelona Supercomputing Center, served as director general for Research for the Government of Catalonia from 2011 to 2016. He is currently an associate professor at the UPC Image Processing and Multimedia Technology Center and an advisor to several technology companies. He graduated in Physics at the University of Barcelona and in General Management at IESE and he also has a PhD in Computer Engineering from the University Ramon Llull.
Eduard Inglés is a branding specialist based in Barcelona. He studied graphic design at Eina, Escola Universitaria de Disseny i Art where he specialized in Branding and Typeface design. Since 2010 he worked on branding global projects with clients such as La Caixa, ExpoHoteles&Resorts, The Style Outlets, Carolina Herrera, La Generalitat and Baku Circuit City. Eduard is developing his skills in Design Management and Branding at SEAT. He also teaches at ELISAVA Design University where he leads a graduate Branding programme.
Reto Schneller is a swiss product designer based in Barcelona. He studied mechanical engneering in Switzerland and industrial design at Umeå Institute of Design, Sweden. «Functional minimalism» does probably best describe his style. His work experience includes brands like Mammut, Garaventa, Scott, Bosch, Leggero, Betty Bossi or Lékué.
Marco Paccagnella is an Italian designer based in Barcelona. He studied industrial and visual design at IUAV University of Venice where he developed a strong dedication in creating meaningful brand experiences. He worked on global digital projects with clients such as Ford motor, Repsol, Lufthansa, NovoNordisk, OXO, Vogue and Samsung. He joined as a visual designer different design consultancy agencies including Fjord and SmartDesign before founding WAA, a studio dedicated to design products for a healthy lifestyle.
Atia Cortés is computer science engineer and master in Artificial Intelligence by the Universitat Politècnica de Catalunya. She is finishing her PhD and is an associate teacher in computer interfaces both at UPC. During the last 10 years she has participated in several national and EU funded research projects related with assistive technologies, intelligent services for healthcare, social networks and robotics.
Inma Valle worked as Independent Advisor and Investor in the Biotechnology sector. She was Investment Manager at Caixa Capital Risc, venture arm of La Caixa, were she lead more than 10 investments in the Life Sciences Sector and sat as Board Member at 4 biotechnology companies. Previously, she spent 4 years working as a researcher at the Diabetes Center at UCSF, where she focused on central regulation of metabolic disorders (obesity, type 2 diabetes, etc). She holds a PhD in Biochemistry & Molecular Biology from University Autónoma of Madrid, and a Master in Biotechnology Management with a focus on healthcare from IE Business School.
Jose Antonio is the Chief Investment Officer at Caixa Capital Risc. He specializes in investment in drug development and medical devices. He currently serves on the Board of Directors at Medlumics, Stat Diagnostica, Laboratoris Sanifit, Genmedica and nLife Therapeutics. He is responsible for the analysis, negotiation and structuring of processes in life science companies. Jose A. has more than 10 years of experience in the analysis of investment opportunities and specializes in the creation and early health sector companies. His experience began in the Department of Business Development at Genzyme Corporation, a company specializing in the development and sale of drugs for orphan diseases. He later joined the Technology Portfolio team at Genoma España, a public sector foundation that promotes technology development, knowledge transfer and innovation in the biotechnology sector. Jose Antonio holds a degree in Biology (Genetics) and a Masters in Corporate Finance from the U. Complutense, Madrid (UCM), MBA and PDD from IESE.
Salvador Llas is a product development engineer. He studied Industrial and Materials Engineering. For the last 10 years he has been working at Neos Surgery as the Head of Product Development, bringing from concept to market implantable medical devices. He is expert on advanced manufacturing technologies and smart materials such shape memory alloys and reinforced materials. During this time, Neos Surgery has received many international awards on Innovation and Design. He is co-inventor of several patents on the medical field. Additionally, he is involved on the worldwide product approval (CE mark, FDA and others) and on regional, national and EU funded projects related with medical devices.
Guillermo Talavera is a physicist (1999), electronic engineer (2001), PhD in Computer Science (2009) and finished a MBA in 2017. After his PhD, he has been several years working in the Universitat Autònoma de Barcelona as teacher, researcher and head of the Wireless Ultra Low Power Area of a research group in the Microelectronics department. From January 2014, he is a Project Manager at IBEC research center. From 2016 he is one of the co-founders of IoT Partners S.L., a hardware and software consultancy in the field of Internet of Things.
Board Member, SOM Biotech (Barcelona)
CEO, Specific Pig (Barcelona)
Managing Partner, Aravis (Zurich)
Institutional relations, Roche Diagnostic (Barcelona)
CEO, Stat Diagnostica (Barcelona)
Biomedical Engineer, Ventura Medical Technologies (Barcelona)
Managing Partner, Neos Surgery (Barcelona)
CEO & Founder, Devicare (Barcelona)
CTO & Co-founder, Subtilis (Barcelona)
CEO, Starlab (Barcelona)
Co-Founder & Chief Executive Officer, Mynorix Therapeutics (Barcelona)
Head Clinics, Hospital Clinic San Carlos (Madrid)
Digital Strategy Consultant, InductES (Barcelona)
CEO & Co-Founder, Miru Medical System (Barcelona)
Once he finished his studies in Molecular Biology in the United Kingdom, Robert decided to change his field and finished his thesis about Computational Chemistry and Molecular Modelling at the University of Barcelona. He was later in charge of the Computational Chemistry and Biology department in one of the reference pharmaceutical companies in Spain, where he gathered more than 12 years of experience in the development of new drugs. From 2011 to 2016 he worked at ZBM Patents and Trademarks where he elaborated patentability and freedom of operation reports, apart from drafting and prosecueing patents in the life sciences field. He is now Chief Scientific Officer of Nostrum Biodiscovery, the first joint spin-off of IRB and BSC.
NIGEL TEN FLEMING
CEO & Co-Founder, ADVentura Capital (Barcelona)
Chief Operating Officer, Transmural Biotech (Barcelona)
Josep Amat, born in 1940, is currently an emeritus Industrial Engineer in the Polytechnic University of Catalonia (UPC). He graduated as an Industrial Engineer in 1976 and later became Doctor in the same field in 1977. Upon completion of his studies he started to collaborate as a student in the Automatics Laboratory and at the same started to give lessons of electronics in the Industrial Engineer School of Barcelona. In 1987, Josep Amat became Professor of Technology and Computers at UPC, and in 2010 was commemorated as an emeritus Professor after his retirement. Between 1991 and 2010 Josep was invited as a partner Professor at the Artificial Intelligence Laboratory of the MIT (Massachusetts, USA). During these last years, he focused his research on two areas: Marine Robotics and Surgical Robotics, working in the Industrial Robotics Institute (IRI) and Biomedical Engineering Robotic Center (CREB). He also worked as a Head of Research for the Research Group of Intelligent Robotics (GRINS) in UPC. Josep Amat is a member of the Catalan Studies Institute since 1990 and also from the Science and Arts Royal Academy of Barcelona since 2000.
Clara Campàs-Moya holds a PhD in Pharmacy by the Universitat de Barcelona. She recently joined Kern Pharma SL as Strategy & Development Director were she coordinates the following departments: R&D, innovation, business development and regulatory affairs. Formerly, she worked at Advancell, SA as Managing Director and Drug development Director, as well as a Researcher at Hospital del Mar. She is the co-author of the patent Acadesine, the first drug originated in a Spanish public University that successfully reached clinical trials. She is member of the scientific committee of the venture capital fund HealthEquity, VicePresident of CataloniaBIO and member of the board of trustees of Biocat, as well as member of the scientific committee of the MIHealth Forum.
Assistant Professor of Surgery, School of Medicine, Stanford University and Stanford Biodesign Faculty (Stanford)
Dan E. Azagury, MD, graduated from medical school in Geneva in 2001 and then completed surgical residency at the Geneva University Hospital. His focus during training was laparoscopy and bariatric surgery, as well as questioning current perioperative management habits such as postoperative nutrition. During this time, he kept a passion for innovation and design, winning second place in a BBraun suture design competition in Switzerland. After completing surgical training and board certification Dan E. Azagury decided to pursue this innovation route further and went to Boston for a research fellowship at the Brigham and Women's Hospital and Harvard Medical School. This fellowship mostly focused on novel endoscopic techniques and device development. Amongst other projects, he participated in the development and experimentation of magnetic anastomoses in the gastrointestinal tract, a gastrointestinal bleeding sensor and endovascular bleeding therapies. He also designed a novel surgical device during that time. He extended his Boston experience with a clinical fellowship in bariatric and minimally invasive surgery at the same institution, the following year. He then decided to further explore his passion for innovation and became a fellow at the Biodesign Fellowship in innovation at Stanford University. This team based fellowship with 3 engineers resulted in two main inventions and projects in the fields of urology and intensive care and the creation of two startup companies. Dan extended his stay at Stanford and focus on the intensive care project with Kate Garrett, his co-fellow during the fellowship. Kate is now CEO of their company, Ciel medical. Dan is now back on faculty in Geneva, in charge of Bariatric surgery at Geneva’s University Hospital and working on innovation projects and programs in collaboration with multiple institutions.
Yossi Bahagon is an entrepreneur with 10 years of leadership-experience in Bio-Medical Informatics and Health Information Sciences. He is the founder and CEO of Health Insight, which is one of the sole companies worldwide which developed a specialty expertise in strategy to realization of e-health, mobile-Health & Tele-Care solutions. In 2008 he founded Clalit Health Services (CHS) Digital Health Division. CHS is the largest health maintenance organization in Israel and the second largest coordinated care organization worldwide with more than 4.2 million members, 10,000+ physicians, 1300+ ambulatory clinics, 14 hospitals and 650 pharmacies. CHS Digital Health division leads next generation, digital-based, patient-centered-care services, focusing on deepening patient involvement in managing health through e-health and mobile health interactive tools. CHS Digital Health activity is considered one of the largest Digital Health operations worldwide and has won several national and international excellence prizes. More than 1.65 million patients use CHS Digital Health monthly, with over 2.6 million interactions. Prior to Dr. Bahagon's position at CHS he served as the Medical Director of the Israeli Clinical Information Center, and as a consultant to CEO positions in the venture capital, Bio-Medical and Pharmaceutical industries. Yossi Bahagon also serves as a lecturer in the fields of Evidence-Based Medicine, Biomedical Informatics and Digital Health at the Hebrew University Hadassah and the Ben-Gurion Medical Schools.
Meike Bomhof is the Senior Associate in Europe at HullAssociates Ltd., a Global Market Access and Reimbursement Consultancy. Since its inception in 2007 she has assisted with the growth of the company in Europe to its present size and provided market access and reimbursement strategy & implementation support related to a wide variety of innovative medical devices mostly in Spain, Italy and The Netherlands. Her main objective is to identify custom made and integrated approaches to market access for a wide range of medical technologies. Prior to her role in HullAssociates she accumulated 14 years of industry experience in the areas of business development, reimbursement, European marketing and finance in Edwards Lifesciences and Baxter where she was responsible amongst other for the evaluation of the viability of commercialization of new products and technologies She started her career in the area of business analysis for European product divisions and finance and controlling for Iberia. Maike Bomhof holds a Postgraduate Diploma Business Administration, International Marketing from University College Dublin and an International Postgraduate Diploma Health Economics from Universitat Pompeu Fabra in Barcelona.
Manel del Castillo, medical specialist in family and community medicine, is Managing Director at Hospital Sant Joan de Déu and the General Secretary of the Consortium for Health and Social Employers Association. He previously served on the Board and Executive Committee at Althaia, was Deputy Director at CHC Consulting and CEO at Hospital Municipal de Badalona, all in Catalonia, Spain.
Roger Piqué is Founder of Inveready Investment Technology Group. He also works as Chief Investment Officer of the company. Previously served as Business Agent at the Finance Department in ACCIÓ - CIDEM.
Moebio Program Manager, Biocat (Barcelona)
Founding Partner and Head of Innovation and Life Sciences, Rousaud Costas Duran (Barcelona)
Ignasi Costas is a financial analyst at the Institute of Financial Studies, expert in mergers, acquisitions and public-economic rights. Member of the Board of Directors of several technology-based companies and VC’s, he is a frequent speaker at private and public forums on venture capital and technology transfer. He is also Visiting Scholar at Columbia University Law School. Dr. Costas holds a Law Degree from the Pompeu Fabra University, a Ph.D. Candidate in Tax Law, University of Barcelona and a Ph.D. Candidate in Corporate Law, University of Almería.
Javier Creus is the founder of Ideas for Change, a strategic think-tank for clients such as Telefónica, Fundeu, Open University of Catalonia, the Basque Goverment and the City Council of Barcelona. Javier is considered to be one of the pioneering strategists and thought leaders in Spain in collaborative economy, open and 2P business models, citizen innovation and the networked society. He has been a freelance strategic planner for many of the most creative agencies in Spain and co-founder of Digital Mood “Internet incubator” and of @kubik multidisciplinary co-working space. Co-author of "We are not ants" he publishes regularily at Yorokobu magazine. Javier is an active member of the Open Knowledge Foundation, Ouishare, the School of Commons and MLove. He holds MBA-s in marketing and communications from the New york University and in international management from ESADE Business School and the Stockholm School of Economics.
Antoni Flores is an expert in competitiveness, innovation and management of new business models; a frequent speaker in business forums and a writer on these topics for general and specialized media. He has advised on strategy, competitiveness and business model design companies such as Hewlett Packard, Inditex, Casals, Steelcase, Bosch Siemens, BBVA, Caja Madrid, Cortefiel, Indra, Danone, Coca Cola. In 2009 he won the Plus Directing Award in the category of SME. Since 2008, Antoni Flores is a member of the commission of innovation of PIMEC (employer’s association) and of the scientific committee of the Andalusian Institute of Technology. In 1990 he founded Competitive Design Network, a leading consulting firm in product development, which later became Loop Business Innovation and expanded into product and services innovation consulting. Antoni Flores is the author of the book La actitud innovadora: cinco principios para generar una nueva forma de gestión (2010, Netbiblo), co-authored Alfons Cornella's book La Alquimia de la Innovación (Ediciones Deusto) and has collaborated with distinguished professionals in books about innovation and design managing. He graduated in mechanical engineering and industrial design.
María José is a personal and executive team coach, consultant and trainer. She designs innovative high performance team training programs with the focus on innovation and communication. Experienced in Leadership and implementation of HR consulting projects, training, coaching, and innovation with PRIZM Game. She directs and presents a tv online program at the Circle of Business Women where they treat issues about Leadership, Communication, People Management, Creativity and Innovation. Graduate in labor relations(UAB), Masters in HR strategy, Executive MBA, licensed Master Practitioner of Neuro-Linguistic Programming (NLP) and licensed in PRIZM Game facilitation.
Professor, Polytechnic University of Catalonia, and Co-Founder , Subtilis Biomaterials (Barcelona)
Doctor in Chemistry, University of Barcelona. Full Professor of Materials Science. Technical University of Catalonia (UPC). Vice president of Research and innovation of the Technical University of Catalonia (UPC). Coordinator of numerous European and National Research Projects. Author of 10 patents. Author of 5 books, more than 250 international research articles in indexed Journals, and 125 communications to International Conferences. Award of the Spanish Royal Society of Chemistry. Award of Technological Transfer. Award to the best scientific communication of Journal of Materials Science: Materials in Medicine. Editor of the Journal of Applied Biomechanics and Biomaterials. Editor of Journal Materials Science: Materials in Medicine. Past President of the Iberian Society of Biomechanics and Biomterials. Member of the Cátedra UNESCO for Biomaterials. Expert of the Comision for Science and Technology in the area of Materials (Biomaterials), of the Spanish Ministry of Education and Science. Research interests: Biomaterials for orthopaedic, dental and cardiovascular applications.
Diana has a degree in Psychology from the University of Barcelona, Post-graduate studies in Human Resources and Industrial Relations from the University Pompeu Fabra and studies with The Coaches Training Institute (CTI). Diana has had a successful career implementing and managing HR processes and also has built an impressive experience as a trainer, facilitator and coach. She works with Executives in Leadership development programs and helping organizations to align culture and strategy. She is Senior Manager with AISGROUP. In this role she manages client projects and delivers training, facilitates team sessions and does executive coaching.
Luis Soenksen is an entrepreneur, professor and researcher focused on incubating appropriate medical technologies for the global market. Currently he is Medtech Entrepreneur and Research Fellow at Massachusetts institute of Technology. Soenksen has extensive experience in the areas of medical product design, bioinstrumentation, medical imaging, biological control and medical innovation. He specializes in the design of ultra low-tech devices with high public health impact, high-end embedded systems for medical applications, software development and need-driven solutions. His previous work has been translated into projects for personal navigation systems in blind patients, imaging post-processing tools for cardiac function, pulmonary embolism diagnosis, catheter design with biofilm control, POC diagnostics, breast cancer screening and wound healing. Luis Soenksen holds a BSc in Biomedical Engineering from the Monterrey Institute of Technology in Mexico City as well as an MSE in Bioengineering Innovation & Design from Johns Hopkins University.
Robert Harju-Jeanty is a healthcare industry expert, an international sales accelerator, and a business growth coach. He has over 25 years of international experience in medical device and pharmaceutical industries from global to start-up companies. He is mentor for the Clinical Innovation Fellowships Program at the Center for Technology in Medicine and Health, a collaborative project between Karolinska Institutet, Royal Institute of Technology and Stockholm County Council to help develop the Stockholm region as a world-class medical technology hub. He represents the Helsinki University Funds as board director in medical portfolio companies. Additionally, he is an advisor and coach in business, communication and venture capital collaborating with various industries, media and universities, mainly in the Nordic countries. He has been lecturer at d·Health Barcelona from the start.
Chia Hwu founded Qubop in 2002 as a mobile production and consulting company. Qubop provides mobile product design, platform consulting, applications and games for the iOS, Android, Windows Phone and BlackBerry platforms. Chia Hwu's background spans product design, marketing, and both hard sciences and the visual arts, and includes seven Silicon Valley startups. Before Qubop, she was Director of Marketing and Developer Outreach at Corona Labs, where she was responsible for leading brand strategy, public relations and product marketing for their mobile tools. Chia previously worked at the Google-funded 23andMe, where she built the company's user communities, created a new product line and social campaign that increased sales by 10x, and managed some of the earliest efforts in marketing genetics to consumers. At Loyalty Lab, Chia sold loyalty programs to major retailers like Smith & Hawken, RedEnvelope and Nine West. Chia has worked in biotech as a medicinal chemist, completed all coursework for a PhD in Chemistry and Biochemistry, received her MS from University of California San Diego, and earned her bachelor's degree from Williams College. She is a coauthor of Teach Yourself the Twitter API in 24 Hours and an expert at the integration of game mechanics and social features into apps.
Senior Adviser and Lecturer on Innovation, Strategic and Commercial Management (Barcelona)
Domingo Jaumandreu is a specialist dedicated to the transfer of professional knowledge and experience on the commercialization of innovative market propositions. He is also a corporate trainer and a visiting professor at the Universitat Politècnica de Catalunya, the Universitat Autònoma de Barcelona and also with the Marketing & Finanzas Business School of Bilbao. Domingo graduated in Aeronautics Engineering at the Polithechnical University of Madrid and subsequently joined the Robert Bosch Group where he contributed in Advanced Materials Engineering, Manufacturing, Logistics and Business to Business middle management positions. By the end of 1982 he joined Sony in Spain serving in Consumer Products Sales, Marketing and Corporate Managing Director responsibilities. After ten years in European assignments, by June 2009 he retired as Senior Vicepresident in charge of Home Digital and Televison Business Group in Sony Electronics Europe, Sony UK Ltd.
Simon Kavanagh is currently the international manager of KaosPilots. His work consists of promoting and creating collaborations between the school and international organizations and co-creating new solutions to learning and creating bridges between the Design and Business worlds. Previously he worked as a Creative Director at Interact Irish Multimedia firm. During these years he designed, programmed or managed approximately 600 multimedia titles in the business, educational, IT, online-Gaming, leisure and banking sectors for such clients as Oracle, Microsoft, Chase, Reuters, Esat and Masterfoods and set up divisions in NYC and Paris. He then became a consultant in R&D for Windmill Lane Studios in the areas of Interactive Television, Content Management systems and online gaming before moving to Paris to further his studies in digital media and art. He re-embarked on the educational path in Shanghai where he lectured a British degree in new media, design and culture for three years, until 2006, when he joined Kaospilots. Simon holds a B.A in Art and Design Education.
Marc Lite is, since 2006, FIRMA branding & innovation agency’s Co-founder and Strategy Director. Prior to launch his own company, in 2001, he was strategic marketing assistant at Hewlett-Packard. One year later, he joined Summa Communication, the leading Spanish branding agency at the time, as Brand Strategy Director. He has worked for clients such as La Caixa, ESADE Business School and Santander. Marc Lite is a professor at ELISAVA Design University where he leads some postgraduate programmes. He also teaches Brand Management at ESADE Business School. Together with Anton Pinyol, he created the workshops The Big Idea and Creativity Immersion, that are among the most current disruptive courses at ESADE. From 2003 to 2006, he was the chief editor of All Brand, a Spanish branding publication. Marc Lite holds a MBA from ESADE. He did his graduating thesis at the Indian Institute of Management in Lucknow.
In over 20 years of professional experience Mario López de Ávila has advised more than 100 organizations, both public and private, large multinational companies and SMEs from 30 different business sectors. In 2002 he launched Nodos, a company specialized in innovation, growth and large-scale organizational change. He advices to organizations how to apply creativity and the ability to integrate join efforts and resources to overcome complex situations and wicked problems that affect the overall performance. In his role as entrepreneur, Mario López de Ávila has been involved in the creation of several technology-based startups as investor and promoter. He combines his work as a consultant and entrepreneur with teaching. He is associate professor at the IE Business School in the area of Operations and Quantitative Methods. At first he teached Project Management and later Creativity and Innovation, complex problem solving and entrepreneurship. He was a pioneer in Spain in translating the principles and methodologies of Lean Startups to large multinational corporate environment. He currently heads 'Owners and Entrepreneurs Management Program' the IE Business School. Renowned lecturer at various forums, Mario López de Ávila has won several awards for excellence in teaching, the latest in 2012, the Award for Innovation in Executive Education at the IE Business School. Since 2004 he owns the blog Nodos, a reference in the field in the Spanish language.
David Maltz is a Principal at Intervalent, and independent consultancy focused on product development and innovation strategy for consumer-facing medical devices. David has worked in product design & development for over 20 years, with the last 14 of those focused exclusively on medical products. This includes extensive inhaled drug-delivery experience with Nektar Therapeutics and Novartis Pharmaceuticals Corporation, where he oversaw the design, development and manufacturing of several novel pulmonary drug delivery systems. Before Nektar, David held leadership positions at Game Ready and Bridge Design. David was deeply involved with Novartis efforts to leverage information technology to improve both clinical study operations (Trials of the Future) and patient outcomes (Digital Medicines), and oversaw the development of all Mobile Medical Apps within Novartis that are regulated as medical devices. He continues to be interested in the harmonious integration of medical devices and information technology, including digital biomarkers. David is passionate about developing sophisticated technologies into human-centric products. His deep understanding of the product development process is seasoned with a strategic perspective and a rich appreciation for the needs of the market and the emotional appeal of any product. David holds a BSE (1989), MBA (2001), and MSE (2002) degrees from Stanford University and lives in San Francisco, California.
Raúl Martín-Ruiz is currently Investment Director at Ysios Capital and chairman of the board of STAT Diagnostica. Ysios is a leading Spanish independent venture capital firm that provides private equity financing to early- and mid-stage human healthcare and biotechnology companies. Prior to joining Ysios in 2008, Raúl worked at Laboratorios Almirall where he was responsible for managing and developing the company’s business through licensees and distributors in America and Africa. Before that, he worked in Almirall’s corporate business development department, focusing on in- and out-licensing. At Almirall he interacted with numerous pharmaceutical and biotech companies on a global basis and coordinated and led evaluation and approval several licensing projects in different therapeutic areas, from the technical, commercial, contractual, financial and business perspectives. Raúl began his career in research. He worked on central nervous system pharmacology in the department of pharmacology of the University of the Basque Country (UPV/EHU), and on neurochemistry in the department of neurochemistry of the Institute for Biomedical Research of Barcelona - Spanish National Research Council (CSIC). Raúl holds a bachelor’s of science in biological sciences from UPV/EHU and a PhD in neurosciences from UPV/EHU and CSIC.
Surgeon, President and Chief Executive Officer (CEO), Ocular Dynamics (Silicon Valley), and Stanford Biodesign Fellow 2010-11.
Vic McCray, MD, is a general surgeon with several years of clinical experience who currently serves as the President and Chief Operating Officer of Ocular Dynamics, where he leads the development of a polymer coating technology for contact lens related dry eye disease. He has received formal training in medical device innovation at Stanford University Biodesign Program and has served as a guest lecturer in entrepreneurship and innovation in several countries. Vic has advised and consulted for a number of startup companies in areas including clinical needs assessment, clinical trial design and business model identification, and has assisted in the genesis of new medical device innovation programs at a number of universities. He has also authored several research publications and is an inventor of a number of pending patents. Vic McCray holds faculty appointments at the University of California, San Francisco and California Northstate University.
Javier Megias is an entrepreneur and investor passionate about innovation and entrepreneurship. He is currently the CEO of STARTUPXPLORE (http://startupxplore.com), a global startup and investor community he founded with a mission: to disrupt the traditional approach to startup-investment growth and to foster transparency and openness in the startup ecosystem. For the past 5 years he has been advising and acting as a board member on several organizations, ranging from startups and VC funds to institutions like the European Commission. He is also an active business angel investor, and is member of the Big BAN board, the largest independent angel investor network in Spain. Javier also writes on the blog http://javiermegias.com/blog, winner of the 2011 award to the best business Spanish-speaking blog of the world.
Paul Natorp is an entrepreneur, a business executive and a creative process leader. He is associated to the KaosPilots school where he co-founded, together with David Storkholm, the Creative Leadership program to train people from all over the world in creative collaboration. He is also co-founder of Sager der Samler, a citizen driven environment for social innovation in Aarhus. Paul has extensive professional experience in innovation management, organizational development and creative leadership and a background as an Olympic athlete. He has been involved in a large number of projects in the private, public and non-profit sectors, in Denmark and internationally, and also in the media and IT-industry. Paul holds a degree in literature and communication from the University of Aarhus.
Founding Partner, Fuelfor Health Care Innovation Design and Consulting (Barcelona - Singapore)
Lekshmy Parameswaran is founding partner and responsible for Insights Research & Strategy at Fuelfor, a design consultancy specialising in healthcare. With over 15 years of collective experience in the health care industry, she has designed research, unique products, services and innovation strategies for healthcare clients in the USA, Europe and Asia. She received training as an architectural engineer and as a product designer.
Anton Pinyol is a branding specialist with more than 16 years of experience. Since 2006, he is the co-founder and Creative Director of FIRMA, an agency that has provided brand management to international companies such as Sony, Pepsico, Unilever, Sara Lee, Abertis Telecom, Levi’s, ESADE Business School, Camper and San Miguel. In 1997 he became consultant for Barcelona Design Center. Two years later, Anton joined Summa Communication as Brand Strategy & Naming Director and worked with clients such as Grupo Planeta, Telefonica (now Movistar) and Orange. He is a professor of Brand Management in ESADE Business School and at EINA Design School, ELISAVA Design University and Universitat Politècnia de Catalunya. Antón Pinyol holds a MBA from ESADE. He did his graduating thesis on Holistic Design Management.
Joan Plans is managing partner of the training and selection consulting firm Directa CDO, SL. Expert in people management, he teaches courses in human resources and is an academic collaborator in the Executive Education Programs at ESADE. He graduated in psychology at the University of Barcelona and holds a MBA from IESE business school.
Engagement Manager, Commercial Effectiveness Services Consulting at IMS Health (Barcelona)
Filippo is an Engagement Manager of the Commercial Effectiveness Services (CES) Consulting team in the Barcelona office, responsible for leading the execution of local consulting projects within the CES area and for business development with pharmaceutical area in the Spanish market. Filippo has a significant experience in consulting for the pharmaceutical industry, in different practice areas of marketing and sales force effectiveness (e.g. new commercial models, sales force sizing, product launch strategy, forecasting, incentive compensation, territory alignment, segmentation and targeting). Selected experience includes: Definition of a new commercial model for adapting to the increasing decentralization of decision power in the Spanish pharmaceutical market. Definition of the sales forecast for a new product launch. International assignment for the definition of the optimal sales force size and structure for two pharmaceutical companies during a merge. Evaluation of the direct sale commercial option as a measure to protect the portfolio against generics. Preparation and facilitation of an SFE Training for the SFE department the Spanish affiliate of a top pharmaceutical company Definition and implementation of strategies for late life cycle management for mature products in the pharmaceutical retail business Filippo holds a degree in Management Engineering from Politecnico of Milan, and an MBA from Instituto de Empresa (Madrid). His mother language is Italian and he speaks fluent English, Spanish and Italian.
Marcel is an economist with more than 18 years of experience in business management, also in financial advisory and asset management. Founding partner of Future Companies, a strategic consulting specialized in growth and investment. Future Companies partners with Crea Inversion an M&A company placed in Pamplona, with offices in Madrid and Barcelona. Marcel’s experience includes incubation and acceleration programs, management of SME, mentoring in spin-offs and start-ups, and the complete process to find investment for growing companies. He has participated in different kinds of corporate processes, including mergers and creation of investment funds. In his portfolio of clients and experience there are several healthcare companies. He has led several companies in investment and professional services sectors, and currently is partner in some of them as Imacity or GuinotPrunera. He’s member of the Advisory Board of the Catalan Institute of Finance. He was General Manager of Economic Promotion of the Generalitat de Catalunya, where he promoted the creation of several financial vehicles.
María Ángeles Quesada is currently the co-founder and CEO of Equánima, a philosophical lab she started in 2009 to help all size of organizations and entrepreneurs seeking innovation. It provides them philosophical skills and tools such as critical thinking, Socratic dialogue, utopian and creative thinking to succeed in the process. María Angeles started her professional career as a researcher at the Spanish National Research Council (CSIC) in the field of Science, Technology and Society Studies. During four years she worked on Converging Technologies (nano, bio, info, cogno) and was involved in big national (INREDIS, Digital Libraries) and European (EthicSchool of Converging Technologies) projects. Afterwards, she studied coaching and emotional intelligence and started to focus on Philosophical Practice and Counseling to, at the end, launch her own company. María Angeles holds Masters degrees in Emotional Intelligence (2011) and NGOs Management (2011) at Universidad Rey Juan Carlos and Universidad Nacional de Educación a Distancia respectively. She graduated in Philosophy at Universidad de Murcia.
Director of Surgical Innovation, Johnson & Johnson (San Francisco) and Stanford Biodesign Fellow 2009-2010
Partha Ray is a venture capitalist, a large-company product manager, a medtech startup co-founder and an information technology consultant with over 16 years of industry experience in the medical technology sector. Currently he is an Executive in Residence at Life Science Angels and a strategic marketing executive at a cardiology startup being funded by Third Rock Ventures and Google Ventures. Previously, he worked at RCT Ventures capital firm, as a Senior Global Product Manager at Medtronic and in engineering and consulting roles at technology companies including IBM, AT&T, Netscape, Scient and Sony. Partha holds a BS in Electrical Engineering from Northwestern University, a MBA from the UCLA Anderson School of Management, and was a Biodesign Innovation Fellow at Stanford University.
Head of the Planning and Health Economics Department, National School of Health - Institute of Health Carlos III (Madrid)
Head of the Planning and Health Economics Department at the National School of Health (Institute of Health Carlos III). Head of Academics of both Master in Health Administration and Medical Management-Clinical Management. Doctor in Medicine (Autonomous University of Madrid) and Master in Planning and Financing Health (University of London). He has also been Principal Scientist at different public research organizations. He has been Director of the Health Department at the National Health Institute of Madrid (INSALUD) and Director-general for Planning, Education and Research of the Ministry of Health of the Madrid Government. He is author of 177 publications, former President of SESPAS and member of some WTO advisory councils.
Anna Riera is currently the responsible of the technical direction of Unió Catalana d’Hospitals, an association of healthcare organizations that provide healthcare and social services for the public healthcare system in Catalonia. She is an expert and has a comprehensive knowledge of healthcare systems field including organization model, healthcare delivery services funding and payment, quality models and innovation. She also works actively, along with providers, to improve public service systems. Previously Riera worked as a doctor, specialized in Internal Medicine, and she is also member of the Global Health Leadership Forum, from University of California Berkeley School of Public Health in partnership with Barcelona Graduate School of Economics and the Universitat Pompeu Fabra Economics and Health Research Center (CRES).. Anna Riera holds a degree in Medicine from Universitat Autónoma de Barcelona as well as a MBA from ESADE Business School.
Luis Ruiz Ávila is one of the founding partners and current CEO of Spherium, a firm that provides operational, strategic and business development expertise to transform into economic value academic knowledge or related projects from established companies in the biomedical sector. His responsibility is the acquisition of projects and further business development. Luis started his career in the industry at Almirall in 1997 as project manager and business developer. In 2001 he left Almirall to participate in creating Advancell, one of the first Spanish biotechnology spin-offs, where he served as CEO from its conception until December 2008, when he left his position to create Janus. In 2002 he participated in the creation of ERA-Plantech (now ERA-Biotech), being interim CEO until 2004, when he became Chairman of its Board of Directors until 2007. In 2009 he served as CEO of the Madrid based company TCD-Pharma, Biotech Crossroads Group. He was a member of the board of Asebio between 2004 and 2008. He is the founder of CataloniaBio, the Catalan association of biotech companies, and member of its board. Luis regularly participates in working groups of local institutions, particularly Biocat. Luis holds a PhD in Molecular Genetics from the Spanish Research Council (CSIC), and, before joining industry, he spent the first 10 years of his career as a researcher and lecturer in different academic positions in various Universities and Research Centers in Spain and in the US (Roche, Mount Sinai NY). He has authored over 25 research papers in prestigious international journals (Nature, PNAS, J. Neurosci) and translated into Spanish several reference textbooks in molecular biology and genetics. He regularly contributes opinion articles on biotechnology management in newspapers and magazines at national level. Occasionally teaches courses in project management and intellectual property, and is an active lecturer in communication and management strategy in the biotechnology and biomedical field.
Deputy Director of Innovation. Head of Health Technology Assessment (HTA) Unit, Hospital Clinic (Barcelona)
Laura Sampietro-Colom is currently the Deputy Director for Innovation at the “Hospital Clinic” in Barcelona, a leading Teaching Hospital in Spain. Prior to this, Dr Sampietro-Colom was the General Director of Information Systems, Projects and Evaluation of the Catalan Health Institute, the leading provider of public health services in the Region of Catalonia (8 Hospitals and 238 Primary Care Centres) and the Director of the Strategic Planning Unit of Health Services within the Planning and Evaluation Directorate of the Ministry of Health of Catalonia. Laura has over 20 years of experience in evaluative research, specifically in HTA and was one of the founders of the Catalan Agency for Health Technology Assessment (nowadays AQuAS) with which she still collaborates as research associate. She was the Founding member of the International Society for Health Technology Assessment (HTAi), serving on the Board of Directors of HTAi since its foundation, including three years as Secretary of the Executive Committee, two years as Vice-President and two years as President. Responsible for the development of one of the research lines of the first international project conducted by the International Network of Agencies for Health Technology Assessment (INAHTA). She has been temporary adviser of the United Nations Agencies WHO and PAHO. Overall, Laura's work has focused on the evaluation of health care technologies, the identification, management and transference of information to improve the decision-making process, and on evidence-based planning healthcare services. Laura is a trained Medical Doctor specializing in Preventive Medicine and Public Health (University of Barcelona) and holds a PhD in Medicine and Surgery by the Autonomous University of Barcelona, and a Master of Science in Public Health by the Rolling School of Public Health (Emory University, Atlanta, USA)
Mercedes Serrano MD PhD works as a child neurologist and clinical researcher expert in metabolic and rare diseases at Sant Joan de Déu Hospital and the Centre for Biomedical Network Research on Rare Diseases (CIBERER). She is very active in exploring new approaches to use information and telecommunications technologies (ICT) to develop new forms of patient oriented research, enable parents to collaborate with researchers on rare diseases and improve the quality of life of patients and their families. She is the founder and principal researcher of www.rarecommons.org, a research Project at the Sant Joan de Déu Hospital in Barcelona focused on the biomedical study of rare diseases that affect children. The undertaking is organized around an online platform that allows for interaction among users, thanks to a dynamic format modeled on virtual social networks and building upon information, learning, and participation. She is also the responsible of the medical contents of www.guiametabolica.org, a reference website for patients suffering inherited metabolic disorders and their families. Mercedes graduated in Medicine at the Miguel Hernández University in Alicante. Later she performed a Master in Child Neurology at the University of Barcelona and a Master in Neurosciences and Biology of Behavior at the University Pablo de Olavide, Sevilla. She gained her PhD degree at the University of Barcelona through her research on dopamine neurotransmission disturbances in pediatric patients. In 2007 she joined CIBERER and Sant Joan de Déu Hospital. She has written dozens of articles indexed in PubMed regarding inherited metabolic disorders including the use of ICT to empower patients and families suffering this group of rare diseases.
David Storkholm has dedicated his life to making people grow. In his own highly professional yet playful way he inspires passion and urges people to meet the world with curiosity. Besides his background in music David is a professional coach and leadership trainer. He has 15 years of experience training young entrepreneurs with a creative edge and a global mindset at the KaosPilot education. David is the Co-founder and program director of The KaosPilot leadership program "Creative Leadership" and a faculty member at the Coaches Training Institute in San Rafael, California.
Montserrat Vendrell has over 10 year experience in biomedical research both in Spanish institutions (CSIC) and international companies (Roche Institute of Molecular Biology). She has been involved in the creation and development of Barcelona Science Park (1997-2007; 2014-2015) as deputy general manager and later, general manager. She was CEO of Biocat for 8 years (2007-2015). She has also been the first director general of the Barcelona Institute of Science and Technology (2015-2017). Montserrat chaired since its birth until 2015, the Council of European Bioregions. She is member of the Board of EADA Business School and RACC. Dr. Vendrell holds a PhD in Biology from University of Barcelona (1991), a master degree in Science Communication from Pompeu Fabra University (Barcelona, 1997) and an Executive Degree in General Management (IESE Business School, Barcelona, PDG-1-2007). She is now General Partner at Alta Life Sciences, a new venture capital investment firm in the field of life sciences in Barcelona.
Rafael Vilasanjuan has been Director of ISGlobal’s Think Tank and Communication since March 2011. Deputy Director of the Centre for Contemporary Culture of Barcelona (CCCB) from 2006 to 2011, he worked for over 12 years with Médecins Sans Frontières (MSF), starting as Communication Director in 1995 and later as General Director of the Spanish section of MSF. In 1999, when the organisation was awarded the Nobel Peace Prize, he was appointed General Secretary of MSF International, organization in which he worked until 2006. As General Secretary of MSF, he was a founder member of the Drugs for Neglected Diseases initiative (DNDi), Mr Vilasanjuan still collaborates with the DNDi. Mr Vilasanjuan is a journalist with a degree in information sciences from the Autonomous University of Barcelona. He has a weekly opinion column on international affairs in El Periódico and contributes weekly as a political affairs analyst on the morning news programme on the leading radio station in Spain (Cadena SER) and on the leading news programme on TV3, Catalonia’s autonomous television network.